Brief: Endovia Health Sciences Advances Cannepil FDA Submission, Expands Pipeline
31/08/2026 21:13
BRIEF-Endovia Health Sciences Advances Cannepil FDA Submission, Expands Pipeline Aug 31 (Reuters) - Endovia Health Sciences, Inc. EDVA.A:
ENDOVIA HEALTH SCIENCES - WELCOMES FEDERAL CANNABINOID POLICY SHIFT, ADVANCES CANNEPIL FDA SUBMISSION, EXPANDS PIPELINE - SEC FILING
ENDOVIA HEALTH SCIENCES - TO SUBMIT CANNEPIL FDA SUBMISSION AND REQUEST PRE-SUBMISSION CONFERENCE IN COMING WEEK - SEC FILING
ENDOVIA HEALTH SCIENCES - IS ALSO ACTIVELY REVIEWING ADDITIONAL CANNABINOID FORMULATIONS AND IP FOR LICENSING, ACQUISITION, COLLABORATION - SEC FILING
ENDOVIA HEALTH SCIENCES - WORKING TO FINALIZE EXPANDED FINANCING FOR DEVELOPMENT, LICENSING, ACQUISITION, OPERATIONS - SEC FILING
Source text: [ID:n0001731122-26-001173]
Further company coverage: EDVA.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endovia Health Sciences
See all newsBrief: Endovia Health Sciences - Enters Letter Agreement With C/M Capital Master Fund On Oct 15, 2026 - SEC Filing
Brief: Endovia Health Sciences Enters Letter Agreement With C/M Capital Master Fund On Sept 18, 2026
Brief: Endovia Health Sciences Advances Cannepil FDA Submission, Expands Pipeline
Brief: Splash Beverage Reports Second Quarter 2026 Results And Highlights Strategic Transformation Toward Endovia Health Sciences
Expands Cannepil License To Veterinary Therapeutics